Weill Cornell Medicine at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Weill Cornell Medicine brings 13 presentations to ObesityWeek 2026 in National Harbor. Its program covers obesity drug treatment and its long-term results, from ten-year metabolic outcomes to diet quality in medically managed patients. It also reports how retatrutide affects knee osteoarthritis pain and how a leptin sensitizer adds to the benefits of semaglutide in obese mice.

OrganizationObesityWeek 2026 Attendance
Universities & research institutes
Medical school of Cornell University in New York City.
Session
Sun Nov 15
9:30am–10:30am
Table 25 - Unpopular Opinions
Potomac Ballroom Foyer (near the windows)
Poster
Sun Nov 15
2:30pm–3:30pm
Poster
Sun Nov 15
2:30pm–3:30pm
Diet Quality in Patients with Medically Managed Obesity
Obesity pharmacotherapy and drug developmentPolicy and public health
Poster
Sun Nov 15
2:30pm–3:30pm
Ten-Year Metabolic Outcomes with Obesity Pharmacotherapy
Obesity pharmacotherapy and drug developmentPolicy and public health
Talk
Sun Nov 15
5:30pm–5:45pm
Talk
Sun Nov 15
5:30pm–5:40pm
Retatrutide in Knee Osteoarthritis: Effects on Pain and Functional Outcomes
Woodrow Wilson, Ballroom Level
Interventional and Clinical Studies · Pediatrics · Chronic Disease
Talk
Sun Nov 15
6:30pm–8:30pm
Clinical Case Files: Following the Metabolic Clues in Obesity and MASLD
Case-based problem-solving on spotting MASLD risk early and coordinating liver and metabolic care for patients with obesity.
Talk hosted by Boehringer Ingelheim
Riverview Ballroom A
with University of Alabama at Birmingham
Metabolism and integrative physiologyClinical obesity care and professional practiceObesity pharmacotherapy and drug developmentChronic disease and obesity complications
Talk
Mon Nov 16
11:45am–12:45pm
Glucagon’s Role in Metabolic Regulation and Why It Matters
Covers how glucagon and the liver regulate glucose and fat metabolism and why this matters in obesity and related heart, kidney and metabolic diseases.
Talk hosted by Boehringer Ingelheim
Riverview Ballroom B
with Wake Forest University, UT Southwestern Medical Center, PAs in Obesity Medicine +1 more
Metabolism and integrative physiologyChronic disease and obesity complications
Session
Mon Nov 16
12:00pm–1:00pm
TOS Clinical Practice Section Meeting (TOS members only) - Obesity Medicine in 2031: What Will It Look Like?
A multidisciplinary panel looks ahead to obesity care in 2031, then the section recognizes its clinician and practitioner awards for obesity care.
Woodrow Wilson, Ballroom Level
with Cleveland Clinic, Yale University, Health Psychology Partners
Clinical obesity care and professional practice
Talk
Mon Nov 16
1:45pm–2:00pm
Talk
Tue Nov 17
8:45am–9:00am
Healthcare Delivery Models From JAMA Summit
Clinical obesity care and professional practicePolicy and public healthObesity pharmacotherapy and drug development

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Weill Cornell Medicine

Tell us what you sell and we’ll find the people at Weill Cornell Medicine most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction